» Global drugmakers News

Global drugmakers

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Drugmakers see a pricing blueprint in an $850,000 gene therapy

Sat, Jan 13, 2018

Spark Therapeutics plans to launch its recently approved Luxturna treatment for an inherited genetic mutation that causes blindness in March

More >